Depressive Disorders - Lithuania | Statista Market Forecast

Revenue in the Depressive Disorders market is projected to reach US$15.21m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 1.94%, resulting in a market volume of US$16.75m by 2029.
In global comparison, most revenue will be generated United States (US$6.26bn in 2024).
In relation to total population figures, per person revenues of US$99.32 are generated in 2024.

Depressive disorders are a common type of mental illness. Symptoms include depressive moods such as feeling sad, low concentration, low self-worth, loss of interest in activities, and, in some cases, thoughts of suicide. Common treatments for depressive disorders include psychological treatments such as psychotherapy, behavioral therapy, and antidepressant medication.

The Depressive Disorders market in the Mental Health market represents the market for antidepressant drug sales. Different types of antidepressants are usually prescribed for the treatment of mild to serious cases of depression, e.g., selective serotonin reuptake inhibitors (SSRIs), serotonin norepinephrine reuptake inhibitor (SNRIs), serotonin modulators, as well as tricyclic and tetracyclic antidepressants.

Market values represent the revenues generated by manufacturers and are based on retail prices for each drug category including all drugs, regardless of whether they are reimbursed or not.

Company examples: Novartis AG, Pfizer, Bristol-Myers Squibb, GlaxoSmithKline, Patheon Inc, and Sandoz Inc.

Antidepressant drugs
Selective serotonin reuptake inhibitors (SSRIs)
Serotonin norepinephrine reuptake inhibitor (SNRIs)
Serotonin modulators
Tricyclic and tetracyclic antidepressants

Psychotherapy
Mood stabilizers
Anti-anxiety and stimulant medications
Behavioral therapy

The Depressive Disorders market in Lithuania is experiencing significant growth and development, driven by several key factors.

Customer preferences: Lithuanian customers are increasingly seeking effective treatments for depressive disorders, leading to a growing demand for pharmaceutical products in this market. They are also becoming more aware of mental health issues and are actively seeking professional help and treatment options. The preference for personalized and holistic approaches to mental health treatment is also on the rise, with customers looking for therapies that address the root causes of depression rather than just managing symptoms.

Trends in the market: One of the major trends in the Depressive Disorders market in Lithuania is the increasing use of antidepressant medications. Lithuanian doctors are prescribing these medications more frequently as they are proven to be effective in managing depressive symptoms. This trend is driven by the growing awareness and acceptance of mental health issues, as well as the availability of a wide range of antidepressant drugs in the market.Another trend in the market is the rise of psychotherapy as a treatment option for depressive disorders. Lithuanian customers are increasingly seeking therapy sessions with mental health professionals to address their mental health concerns. This trend is fueled by the growing recognition of the importance of psychological well-being and the effectiveness of therapy in managing and overcoming depressive disorders.

Local special circumstances: Lithuania has a high prevalence of depressive disorders compared to other countries in the region. This can be attributed to various factors, including the country's history of political and social instability, economic challenges, and a high suicide rate. The local special circumstances contribute to the increased demand for treatment options and the growing focus on mental health in the country.

Underlying macroeconomic factors: The overall economic development and stability in Lithuania have also played a role in the growth of the Depressive Disorders market. As the country's economy continues to improve, more resources are being allocated to healthcare, including mental health services. This has led to an increase in the availability and accessibility of treatment options for depressive disorders, further driving the growth of the market.In conclusion, the Depressive Disorders market in Lithuania is witnessing significant growth and development due to increasing customer preferences for effective treatments, the use of antidepressant medications, the rise of psychotherapy, the high prevalence of depressive disorders in the country, and the overall economic development and stability. These factors have created a favorable environment for the expansion of the market and the provision of better mental health services to Lithuanian customers.

Data coverage:

Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Despite what some may think, mental health problems are common in the United States and around the world. Mental health issues, much like other health issues, can be mild, but can also be life altering, affecting the emotional, social, and psychological well-being of the person. Common types of mental illness include mood disorders, anxiety disorders, eating disorders, and personality disorders. Although symptoms of mental illness differ depending on the type of illness and seriousness of the problem, common symptoms of mental health issues include changes in sleeping and eating habits, social withdrawal, feelings of hopelessness, anger, and prolonged sadness, suicidal thoughts, and substance abuse. In 2022, it was estimated that around 36 percent of those in the U.S. aged 18 to 25 years and 29 percent of those aged 26 to 49 years suffered from some form of mental illness in the past year.